Literature DB >> 14715269

Transcriptional silencing of the RUNX3 gene by CpG hypermethylation is associated with lung cancer.

Qing-Lin Li1, Hye-Ryeon Kim, Wun-Jae Kim, Joong-Kook Choi, Yong Hee Lee, Hwan-Mook Kim, Long Shan Li, Hoguen Kim, Joon Chang, Yoshiaki Ito, Kwang Youl Lee, Suk-Chul Bae.   

Abstract

RUNX family transcription factors are integral components of TGF-beta signaling pathways and have been implicated in cell cycle regulation, differentiation, apoptosis, and malignant transformation. It was noted previously that allele loss and loss of expression of RUNX3 are causally involved in gastric carcinogenesis. Our results demonstrate that RUNX3 is inactivated by aberrant DNA methylation in approximately 19% of lung cancer cell lines and 24% of primary lung cancer specimens. RUNX3 methylation is tumor-specific, since it is not observed in surrounding normal lung tissues. Our results suggest that loss of RUNX3 expression by DNA hypermethylation is frequently associated with the evolution of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715269     DOI: 10.1016/j.bbrc.2003.12.079

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  39 in total

1.  RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status.

Authors:  Mohd Feroz Mohd Omar; Kosei Ito; Min En Nga; Ross Soo; Bee Keow Peh; Tuty Muliana Ismail; Bhavin Thakkar; Richie Soong; Yoshiaki Ito; Manuel Salto-Tellez
Journal:  Pathol Oncol Res       Date:  2012-06-24       Impact factor: 3.201

Review 2.  Epigenetics of lung cancer.

Authors:  Scott M Langevin; Robert A Kratzke; Karl T Kelsey
Journal:  Transl Res       Date:  2014-03-12       Impact factor: 7.012

3.  Epigenetic changes induced by oxidative stress in colorectal cancer cells: methylation of tumor suppressor RUNX3.

Authors:  Kyoung Ah Kang; Rui Zhang; Gi Young Kim; Suk Chul Bae; Jin Won Hyun
Journal:  Tumour Biol       Date:  2012-01-25

4.  RUNX3 modulates DNA damage-mediated phosphorylation of tumor suppressor p53 at Ser-15 and acts as a co-activator for p53.

Authors:  Chizu Yamada; Toshinori Ozaki; Kiyohiro Ando; Yusuke Suenaga; Ken-ichi Inoue; Yoshiaki Ito; Rintaro Okoshi; Hajime Kageyama; Hideki Kimura; Masaru Miyazaki; Akira Nakagawara
Journal:  J Biol Chem       Date:  2010-03-30       Impact factor: 5.157

5.  Application of RUNX3 gene promoter methylation in the diagnosis of non-small cell lung cancer.

Authors:  Gui-Ping Yu; Yong Ji; Guo-Qiang Chen; Bin Huang; Kai Shen; Song Wu; Zhen-Ya Shen
Journal:  Oncol Lett       Date:  2011-10-19       Impact factor: 2.967

6.  The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer.

Authors:  Liudmila L Kodach; Rutger J Jacobs; Jarom Heijmans; Carel J M van Noesel; Alexandra M J Langers; Hein W Verspaget; Daniel W Hommes; G Johan A Offerhaus; Gijs R van den Brink; James C H Hardwick
Journal:  Carcinogenesis       Date:  2010-07-14       Impact factor: 4.944

7.  Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer.

Authors:  Mónica Castro; Laura Grau; Patricia Puerta; Liliana Gimenez; Julio Venditti; Silvia Quadrelli; Marta Sánchez-Carbayo
Journal:  J Transl Med       Date:  2010-09-17       Impact factor: 5.531

8.  Lung cancer stem cell: new insights on experimental models and preclinical data.

Authors:  Caroline Rivera; Sofia Rivera; Yohann Loriot; Marie-Catherine Vozenin; Eric Deutsch
Journal:  J Oncol       Date:  2010-12-16       Impact factor: 4.375

9.  Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm.

Authors:  Yun-Mi Goh; Senthilkumar Cinghu; Eileen Tan Hwee Hong; You-Soub Lee; Jang-Hyun Kim; Ju-Won Jang; Ying-Hui Li; Xin-Zi Chi; Kyeong-Sook Lee; Heejun Wee; Yoshiaki Ito; Byung-Chul Oh; Suk-Chul Bae
Journal:  J Biol Chem       Date:  2010-01-25       Impact factor: 5.157

10.  Aberrant epigenetic silencing is triggered by a transient reduction in gene expression.

Authors:  Jon A Oyer; Adrian Chu; Sukhmani Brar; Mitchell S Turker
Journal:  PLoS One       Date:  2009-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.